Commonwealth Equity Services
MBIO icon

Commonwealth Equity Services’s Mustang Bio MBIO Stock Holding History

Commonwealth Equity Services’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-71
Closed -$19 – 3886
2023
Q1 		$19 Buy
71
+7
+11% +$2.87K ﹤0.01% 3675
2022
Q4 		$18K Buy
64
+20
+45% +$6.83K ﹤0.01% 3605
2022
Q3 		$15K Buy
44
+18
+69% +$8.34K ﹤0.01% 3599
2022
Q2 		$11K Buy
+26
New +$14.4K ﹤0.01% 3617
2022
Q1 		– Sell
-14
Closed -$17K – 3764
2021
Q4 		$17K Hold
14
– – ﹤0.01% 3613
2021
Q3 		$28K Hold
14
– – ﹤0.01% 3534
2021
Q2 		$34K Buy
+14
New +$34.3K ﹤0.01% 3482

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Commonwealth Equity Services's MBIO Position: Q2 2023 in Review

Commonwealth Equity Services sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 71 shares — an estimated $19 sold.

Commonwealth Equity Services first reported a position in MBIO in Q2 2021 and held it in 7 quarters. The position peaked at $34K in Q2 2021. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

  • Commonwealth Equity Services reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 71 Mustang Bio shares in Q2 2023, an estimated $19.
  • Commonwealth Equity Services first reported a position in Mustang Bio in Q2 2021 and held it in 7 quarters.
  • Commonwealth Equity Services's Mustang Bio position peaked at $34K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Commonwealth Equity Services's 13F filing for Q2 2023, filed 10 Aug 2023.